- Corporate Officers - S
- Sorrento Therapeutics, Inc.
Insider Trading History of Sorrento Therapeutics, Inc.
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Sorrento Therapeutics, Inc. since 2023.
This trader's CIK number is 850261.
At the time of last reporting, Sorrento Therapeutics, Inc. was the Officer of Celularity Inc. (stock ticker symbol CELU).
Also see all insider trading activities at Celularity Inc.
Note that in the past
Sorrento Therapeutics, Inc. also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Scilex Holding Co (SCLX) by Sorrento Therapeutics, Inc.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | SCLX | 0 | $0 | 60,068,585 | $0 | 0 | $0 |
Yearly summary of insider trading at Celularity Inc (CELU) by Sorrento Therapeutics, Inc.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | CELU | 0 | $0 | 15,371,697 | $0 | 0 | $0 |
Insider trading activities at 2 companies by Sorrento Therapeutics, Inc.:
1. Scilex Holding Co (SCLX)
2. Celularity Inc (CELU)
Table 1. Insider trading of Scilex Holding Co (SCLX) by Sorrento Therapeutics, Inc.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-09-21 | SCLX | Sale | 60,068,585 | .00 | 0 |
Table 2. Insider trading of Celularity Inc (CELU) by Sorrento Therapeutics, Inc.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-10-05 | CELU | Sale | 6,307,158 | .00 | 0 |
| 2023-09-29 | CELU | Sale | 9,064,539 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Sorrento Therapeutics, Inc.
(Officer of Celularity Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.